Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer

PURPOSE: To determine the activity and toxicities of low dose leucovorin (LV) plus fluorouracil (5-FU) regimen, combined with oxaliplatin every two weeks (modified FOLFOX 4), as a first-line therapy for patients with metastatic colorectal cancer. MATERIALS AND METHODS: Between March 2001 and August...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kwon, Hyuk-Chan, Kim, Kyoung Tae, Lee, Shin Ae, Park, Jong-Sung, Kim, Sung-Hyun, Kim, Jae-Seok, Kim, Hyo Jin
Formato: Artigo
Idioma:Inglês
Publicado: Korean Cancer Association 2004
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855099/
https://ncbi.nlm.nih.gov/pubmed/20396550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2004.36.2.115
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares